Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer
Clinical trial NCT00704730 · COMPLETED
Trial details
- NCT number
- NCT00704730
- Sponsor
- Exelixis
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-01
- Primary completion
- 2011-10-01
- Enrollment
- 330
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.